Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Blut|July 1, 1988
Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remissionD S Snyder, D O Findley, S J Forman, et al.
Transplantation|March 1, 1993
Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of lifeG M Schmidt, J C Niland, S J Forman, et al.
Transplantation|March 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remissionK G Blume, S J Forman, D S Snyder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centersR Storb, K G Blume, M R O'Donnell, et al.
Bone Marrow Transplantation|July 5, 2001
Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulinH Khoury, A Kashyap, D R Adkins, et al.
Bone Marrow Transplantation|August 29, 2007
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndromeR Nakamura, R Rodriguez, J Palmer, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
Leukemia|June 1, 2011
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaM H Kirschbaum, T Synold, A S Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survivalG Somlo, J H Doroshow, S J Forman, et al.
Blood|March 1, 1983
Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemiaS J Forman, W E Spruce, M J Farbstein, et al.
Pageof 18